MCCLUSKI STEPHEN C 4
4 · ImmunoGen, Inc. · Filed Sep 14, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
MCCLUSKI STEPHEN C
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-09-13−10,000→ 0 totalExercise: $14.70Exp: 2023-11-12→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2023-09-13$14.70/sh+10,000$147,000→ 10,000 total - Exercise/Conversion
Common Stock
2023-09-13$16.05/sh−10,000$160,500→ 0 total
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on June 14, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.90 to $16.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
- [F3]This option was granted on 11/12/2013 and is fully vested as of the transaction date.